Synutra International, Inc.  

(Public, NASDAQ:SYUT)   Watch this stock  
Find more results for SYUT
4.58
-0.09 (-1.93%)
May 20 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 4.48 - 4.64
52 week 3.80 - 6.30
Open 4.64
Vol / Avg. 7,009.00/14,692.00
Mkt cap 262.44M
P/E     -
Div/yield     -
EPS -1.04
Shares 57.30M
Beta 2.19
Inst. own 41%

Key stats and ratios

Q4 (Dec '12) 2012
Net profit margin -18.37% 4.97%
Operating margin 0.49% 12.49%
EBITD margin - 15.93%
Return on average assets -12.34% 4.02%
Return on average equity -165.08% 19.54%
Employees 4,250 -
Carbon Disclosure Rating - -

Address

Suite 500, 2275 Research Blvd.
ROCKVILLE, MD 20850
United States - Map
+1-301-8403888 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Synutra International, Inc. is an infant formula company in China. The Company principally produces, markets and sells its products under the Shengyuan or Synutra name, together with other brands. Powdered formula segment covers the sale of powdered infant and adult formula products under Super, U-Smart, My Angel and Helanruniu brands. Baby food segment covers the sale of baby foods under the Huiliduo brand. Nutritional ingredients and supplements segment covers the production and sale of nutritional ingredients and supplements. Its other business includes non-core businesses, such as sales of milk powder, whey protein and raw milk to industrial customers. It sells its products through nationwide sales and distribution networks covering all provinces and provincial-level municipalities in mainland China. As of March 31, 2012, this network consisted over 650 independent distributors and over 800 independent sub-distributors who sell the Company's products in over 67,000 retail outlets.

Officers and directors

Liang Zhang Chairman of the Board, Chief Executive Officer
Age: 52
Bio & Compensation  - Reuters
Weiguo Zhang President
Age: 55
Bio & Compensation  - Reuters
Ning Cai Chief Financial Officer
Age: 37
Bio & Compensation  - Reuters
Feng Zha Vice President - Human Resources and Administration
Age: 49
Bio & Compensation  - Reuters
Xisen Mu Vice President - Production
Age: 55
Bio & Compensation  - Reuters
Joseph Chow Director
Age: 50
Bio & Compensation  - Reuters
Donghao Yang Director
Age: 40
Bio & Compensation  - Reuters
Jinrong Chen Independent Director
Age: 53
Bio & Compensation  - Reuters
Hui Li Independent Director
Age: 44
Bio & Compensation  - Reuters
Lei Lin Independent Director
Age: 45
Bio & Compensation  - Reuters